IMCD N.V. (IMDZF)

Compare

143.25

0.00

(0.00%)

At close: March 26 at 4:00:00 PM EDT

IMCD N.V.'s (AMS:IMCD) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

IMCD (AMS:IMCD) has had a rough three months with its share price down 17%. However, stock prices are usually driven by...

Simply Wall St. 1 hour ago

IMCDY

IMDZF
0.00%
IMCD's (AMS:IMCD) investors will be pleased with their impressive 118% return over the last five years

IMCD N.V. ( AMS:IMCD ) shareholders might be concerned after seeing the share price drop 14% in the last month. But...

Simply Wall St. 14 days ago

IMCDY

IMDZF
0.00%
IMCD Full Year 2024 Earnings: In Line With Expectations

IMCD ( AMS:IMCD ) Full Year 2024 Results Key Financial Results Revenue: €4.75b (up 6.4% from FY 2023). Net income...

Simply Wall St. 29 days ago

IMCDY

IMDZF
0.00%
IMCD NV (IMCDY) (Q4 2024) Earnings Call Highlights: Strategic Acquisitions and Robust Cash Flow ...

IMCD NV (IMCDY) reports strong financial performance with significant acquisitions in life sciences, despite facing inflationary pressures and geopolitical uncertainties.

GuruFocus.com last month

IMCDY
IMCD reports EBITA growth to EUR 531 million in 2024

Rotterdam, The Netherlands (5 March 2025) - IMCD N.V. (“IMCD” or “Company”), a global leading distribution partner, and formulator of speciality chemicals and ingredients, today announces its full year 2024 results. HIGHLIGHTS• Gross profit growth of 7% to EUR 1,202 million (+9% on a constant currency basis)• Operating EBITA increase of 3% to EUR 531 million (+5% on a constant currency basis)• Net result for the year of EUR 278 million (-4% on a constant currency basis)• Free cash flow of EUR 45

GlobeNewswire last month

IMCDY

IMDZF
0.00%
IMCD takes the next steps in its decarbonisation journey and commits to set SBTi near-term targets

ROTTERDAM, The Netherlands (3 March 2025) – IMCD N.V. ("IMCD" or "Company"), a global leading distribution partner and formulator of speciality chemicals and ingredients, today announced it has committed to the Science Based Target initiative (SBTi) and intends to set near-term emissions reduction targets in line the SBTi criteria and recommendations. The SBTi is a corporate climate action organisation that enables companies and financial institutions worldwide to play their part in combating th

GlobeNewswire last month

IMCDY

IMDZF
0.00%
With 60% institutional ownership, IMCD N.V. (AMS:IMCD) is a favorite amongst the big guns

Key Insights Institutions' substantial holdings in IMCD implies that they have significant influence over the company's...

Simply Wall St. last month

IMCDY

IMDZF
0.00%
Calculating The Intrinsic Value Of IMCD N.V. (AMS:IMCD)

Key Insights Using the 2 Stage Free Cash Flow to Equity, IMCD fair value estimate is €175 Current share price of €151...

Simply Wall St. 2 months ago

IMCDY

IMDZF
0.00%
IMCD to acquire the life science business of YCAM in South Korea and expand its footprint in the beauty and personal care markets

IMCD to acquire the life science business of YCAM in South Korea From left to right: JaeJoong Kim, Sales Director of YCAM, Fenna van Zanten, Director M&A and member of IMCD Group Executive Committee, Munkyum Kim, CEO of YCAM, Dongjoon Lee, Managing Director of IMCD Korea, Peter Shin, Finance Director of IMCD Korea ROTTERDAM, The Netherlands (18 December 2024) – IMCD N.V. ("IMCD" or "Company"), a global leading distribution and formulation partner of speciality chemicals and ingredients, has sign

GlobeNewswire 3 months ago

IMCDY

IMDZF
0.00%
IMCD China strengthens its life science business with the acquisition of Daoqin

Photo_IMCD China strengthens its lifescience business with the acquisition of Daoqin (Left) Nicky Huang, Managing Director of IMCD China and IMCD Sanrise(Right) Jack Ning, General Manager of Daoqin ROTTERDAM, The Netherlands (13 December 2024) – IMCD N.V. ("IMCD" or "Company"), a global leading distribution partner and formulator of speciality chemicals and ingredients, today announces that IMCD has signed an agreement to acquire the business of the food and nutraceutical ingredient distributor:

GlobeNewswire 3 months ago

IMCDY

IMDZF
0.00%
At €142, Is IMCD N.V. (AMS:IMCD) Worth Looking At Closely?

IMCD N.V. ( AMS:IMCD ), is not the largest company out there, but it saw significant share price movement during recent...

Simply Wall St. 4 months ago

IMCDY

IMDZF
0.00%
IMCD N.V. successfully raises EUR 300 million through an accelerated bookbuild offering of new shares

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, INTO OR IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH OFFERS OR SALES WOULD BE PROHIBITED BY APPLICABLE LAW. THIS ANNOUNCEMENT DOES NOT CONSTITUTE OR FORM AN OFFER OF SECURITIES IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION.PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT.ROTTERDAM, The Netherlands (13

GlobeNewswire 4 months ago

IMCDY

IMDZF
0.00%
IMCD N.V. LAUNCHES A CAPITAL RAISE OF EUR 300 MILLION TO INCREASE FINANCIAL FLEXIBILITY

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, INTO OR IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH OFFERS OR SALES WOULD BE PROHIBITED BY APPLICABLE LAW. THIS ANNOUNCEMENT DOES NOT CONSTITUTE OR FORM AN OFFER OF SECURITIES IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION.PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT. ROTTERDAM, The Netherlands (1

GlobeNewswire 4 months ago

IMCDY

IMDZF
0.00%
IMCD NV (IMCDY) Q3 2024 Earnings Call Highlights: Strong EBITA Growth Amid Market Volatility

IMCD NV (IMCDY) reports robust EBITA growth and strategic acquisitions, while navigating market uncertainties and cash flow challenges.

GuruFocus.com 4 months ago

IMCDY
IMCD reports EBITA of EUR 403 million in the first nine months of 2024

Rotterdam, The Netherlands (8 November 2024) - IMCD N.V. (“IMCD” or “Company”), a global leading distribution partner, and formulator of speciality chemicals and ingredients, today announces its first nine months 2024 results.HIGHLIGHTS• Gross profit increase of 6% to EUR 909 million (+8% on a constant currency basis)• Operating EBITA increase of 1% to EUR 403 million (+3% on a constant currency basis)• Free cash flow of EUR 299 million (first nine months of 2023: EUR 364 million)• Cash earnings

GlobeNewswire 4 months ago

IMCDY

IMDZF
0.00%
Returns At IMCD (AMS:IMCD) Appear To Be Weighed Down

There are a few key trends to look for if we want to identify the next multi-bagger. In a perfect world, we'd like to...

Simply Wall St. 5 months ago

IMCDY

IMDZF
0.00%
IMCD acquires Blumos Group to accelerate its growth in the life science markets in Latin America

Photo_IMCD acquires Blumos Group to accelerate its growth in the life science markets in Latin America Photographed, from left to right:•Roberto Blum, CEO Blumos Group •Myriam Araya, General Manager Solutec•Nicolas Kaufmann, Latin America President IMCD•Ofelia Carranza, General Manager Sonutra Blumos•Nicolas Kantorowicz, General Manager Blumos S.A ROTTERDAM, The Netherlands (17 October 2024) – IMCD N.V. (“IMCD” or “Company”), a global leading distributor of speciality chemicals and ingredients,

GlobeNewswire 5 months ago

IMDZF
0.00%
Those who invested in IMCD (AMS:IMCD) five years ago are up 130%

The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But on the bright side, if...

Simply Wall St. 5 months ago

IMDZF
0.00%
Can IMCD N.V. (AMS:IMCD) Maintain Its Strong Returns?

While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...

Simply Wall St. 6 months ago

IMDZF
0.00%
With 57% ownership, IMCD N.V. (AMS:IMCD) boasts of strong institutional backing

Key Insights Given the large stake in the stock by institutions, IMCD's stock price might be vulnerable to their...

Simply Wall St. 6 months ago

IMDZF
0.00%

Performance Overview

Return	IMDZF	AEX-Index (^AEX)
YTD	-5.76%	-9.98%
1-Year	-15.60%	-10.19%
3-Year	-3.02%	+10.38%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

IMCD N.V. (IMDZF)

IMCD N.V.'s (AMS:IMCD) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

IMCD's (AMS:IMCD) investors will be pleased with their impressive 118% return over the last five years

IMCD Full Year 2024 Earnings: In Line With Expectations

IMCD NV (IMCDY) (Q4 2024) Earnings Call Highlights: Strategic Acquisitions and Robust Cash Flow ...

IMCD reports EBITA growth to EUR 531 million in 2024

IMCD takes the next steps in its decarbonisation journey and commits to set SBTi near-term targets

With 60% institutional ownership, IMCD N.V. (AMS:IMCD) is a favorite amongst the big guns

Calculating The Intrinsic Value Of IMCD N.V. (AMS:IMCD)

IMCD to acquire the life science business of YCAM in South Korea and expand its footprint in the beauty and personal care markets

IMCD China strengthens its life science business with the acquisition of Daoqin

At €142, Is IMCD N.V. (AMS:IMCD) Worth Looking At Closely?

IMCD N.V. successfully raises EUR 300 million through an accelerated bookbuild offering of new shares

IMCD N.V. LAUNCHES A CAPITAL RAISE OF EUR 300 MILLION TO INCREASE FINANCIAL FLEXIBILITY

IMCD NV (IMCDY) Q3 2024 Earnings Call Highlights: Strong EBITA Growth Amid Market Volatility

IMCD reports EBITA of EUR 403 million in the first nine months of 2024

Returns At IMCD (AMS:IMCD) Appear To Be Weighed Down

IMCD acquires Blumos Group to accelerate its growth in the life science markets in Latin America

Those who invested in IMCD (AMS:IMCD) five years ago are up 130%

Can IMCD N.V. (AMS:IMCD) Maintain Its Strong Returns?

With 57% ownership, IMCD N.V. (AMS:IMCD) boasts of strong institutional backing

Performance Overview